COMMON STOCK PURCHASE WARRANT hemispherx biopharma, inc.Common Stock Purchase Warrant • February 3rd, 2017 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 6, 2017 (the “Initial Exercise Date”) and on or prior to the close of business on five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hemispherx BioPharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 3rd, 2017 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2017, between Hemispherx BioPharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
January 13, 2017 STRICTLY CONFIDENTIAL Hemispherx BioPharma, Inc.Exclusive Agency Agreement • February 3rd, 2017 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
